Who Exports Neosporin from India — 99 Suppliers Behind a $99.9K Market
India's neosporin export market is supplied by 99 active exporters who collectively shipped $99.9K across 815 shipments. PARAGON DIAGNOSTICS leads with a 10.3% market share, followed by ANBU AGENCIES and GET EXPORTS & IMPORTS SHOP. The top 5 suppliers together control 43.5% of total export value, reflecting a moderately competitive market structure.
Top Neosporin Exporters from India — Ranked by Export Value
PARAGON DIAGNOSTICS is the leading neosporin exporter from India, holding a 10.3% share of the $99.9K market across 815 shipments from 99 exporters. The top 5 suppliers — PARAGON DIAGNOSTICS, ANBU AGENCIES, GET EXPORTS & IMPORTS SHOP, CAPSTONE EXPORT & IMPORT, VEA IMPEX (I) PRIVATE LIMITED — collectively control 43.5% of total export value, indicating a competitive market. Individual shares are: PARAGON DIAGNOSTICS (10.3%), ANBU AGENCIES (10.3%), GET EXPORTS & IMPORTS SHOP (9.8%), CAPSTONE EXPORT & IMPORT (6.7%), VEA IMPEX (I) PRIVATE LIMITED (6.4%).
Top Neosporin Exporters from India
Ranked by export value · 99 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | PARAGON DIAGNOSTICS NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $10.3K | 1 | 10.3% |
| 2 | ANBU AGENCIES NEOSPORIN OINTNEOSPORINE SKIN OINT.. | $10.3K | 1 | 10.3% |
| 3 | GET EXPORTS & IMPORTS SHOP NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $9.8K | 1 | 9.8% |
| 4 | CAPSTONE EXPORT & IMPORT NEOSPORIN POWDERNEOSPORIN SKIN OINTMENTNEOSPORIN SKIN OINT (NEOMYCIN PO | $6.7K | 1 | 6.7% |
| 5 | VEA IMPEX (I) PRIVATE LIMITED NEOSPORIN POWDERNEOSPORIN SKIN OINTMENTOINTMENT NEOSPORIN H OINT-NEOMYCIN & POLYMIXIN B -5GM | $6.4K | 8 | 6.4% |
| 6 | HEMS ( INDIA ) NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $6.2K | 2 | 6.2% |
| 7 | KOMAL EXPORTERS NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $5.2K | 1 | 5.2% |
| 8 | TULSI MEDICAL & GENERAL STORES NEOSPORIN OINT BACITRACIN + NEOMPHARMACEUTICALS PRODUCTS NEOSPORIN SKINNEOSPORIN POWDER(BACITRACIN + NEOMYCIN | $4.4K | 20 | 4.4% |
| 9 | N CHIMANLAL ENTERPRISES NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN OINTNEOSPORIN - H OINTMENT 5GM | $2.4K | 5 | 2.4% |
| 10 | ARIHANT EXPORTERS OINTMENT NEOSPORIN H OINT-NEOMYCIN & POLYMIXIN B -5GMNEOSPORIN OINTMENTNEOSPORIN OINTMENT 10GM | $2.1K | 1 | 2.1% |
| 11 | AYYA PHARMACEUTICALS NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $2.0K | 1 | 2.0% |
| 12 | VEA IMPEX I PRIVATE LIMITED NEOSPORIN POWDERNEOSPORIN SKIN OINTMENTOINTMENT NEOSPORIN H OINT-NEOMYCIN & POLYMIXIN B -5GM | $1.9K | 7 | 1.9% |
| 13 | GET EXPORTS IMPORTS SHOP NEOSPORIN ANTIBIOTIC OINTMENT 10GMNEOSPORIN - H OINTMENT 5GMNEOSPORIN OINTMENT (PHARMACEUTICAL | $1.7K | 1 | 1.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Neosporin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Centaur Pharmaceuticals Private Ltd. | Warning Letter, July 2023 | Unknown | Unknown | Not verified | FDA issued a warning letter citing significant CGMP violations. |
| GPT Pharmaceuticals Private Ltd. | Warning Letter, December | Unknown | Unknown | Not verified | FDA cited significant CGMP violations in warning letter. |
| Kenil Healthcare Private Limited | Warning Letter, June 2025 | Unknown | Unknown | Not verified | FDA issued warning letter for CGMP violations. |
| Intas Pharmaceuticals Limited | Warning Letter, November | Unknown | Unknown | Not verified | FDA cited significant CGMP violations in warning letter. |
| Jagsonpal Pharmaceuticals Limited | Warning Letter, February | Unknown | Unknown | Not verified | FDA issued warning letter for CGMP deviations. |
| Centrient Pharmaceuticals India Private Limited | Warning Letter, December | Unknown | Unknown | Not verified | FDA cited significant CGMP deviations in warning letter. |
| Rxhomeo Private Limited | Warning Letter, June 2019 | Unknown | Unknown | Not verified | FDA issued warning letter for CGMP violations. |
TransData Nexus reviewed the regulatory standing of 7 leading Neosporin exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 7 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Neosporin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous manufacturing units specializing in APIs, which are essential components in formulations like Neosporin. The presence of a robust infrastructure and a skilled workforce makes Hyderabad a strategic location for sourcing bulk drugs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region houses a significant number of manufacturing units dedicated to producing finished dosage forms, including ointments and creams. Companies in this cluster are known for their adherence to international quality standards, making it a reliable source for Neosporin formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. With its proximity to major ports and well-established logistics networks, this region facilitates efficient distribution of products like Neosporin to international markets. The concentration of export-oriented units in this area underscores its importance in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives. This area attracts numerous companies producing a variety of pharmaceutical products, including ointments. The cost advantages offered by this cluster can be beneficial for sourcing Neosporin at competitive prices.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and quality standards of suppliers in the Hyderabad and Ahmedabad-Vadodara clusters to ensure consistent API and formulation quality.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline the export process and reduce lead times for international shipments.
- Consider Cost Benefits: Explore sourcing options in the Baddi-Nalagarh cluster to take advantage of tax incentives and potentially lower production costs.
- Ensure Regulatory Compliance: Verify that all suppliers comply with international regulatory standards to maintain product integrity and facilitate smooth market entry.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize its supply chain for Neosporin, ensuring quality, cost-effectiveness, and efficient distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Neosporin exporters from India
VEA IMPEX (I) PRIVATE LIMITED — VEA IMPEX (I) PRIVATE LIMITED registers with Indian Customs
VEA IMPEX (I) PRIVATE LIMITED completed its registration with Indian Customs, as documented in the official records. - IMPACT: This registration facilitates VEA IMPEX's export operations, potentially enhancing their Neosporin export capabilities.
Impact: This registration facilitates VEA IMPEX's export operations, potentially enhancing their Neosporin export capabilities.
Common Questions — Neosporin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which neosporin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, PARAGON DIAGNOSTICS leads with 5 recorded shipments worth $10.3K. ANBU AGENCIES (7 shipments) and GET EXPORTS & IMPORTS SHOP (30 shipments) are also established high-volume exporters.
Q How many neosporin manufacturers are there in India?
India has 99 active neosporin exporters with a combined export market of $99.9K across 815 shipments to 62 countries. The top 5 suppliers hold 43.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for neosporin from India?
Average FOB unit price: $3.06 per unit, ranging from $0.17 to $204.25. Average shipment value: $123.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 99 verified Indian exporters of Neosporin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 815 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 62 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
815 Verified Shipments
99 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists